1. Pink Sheet
  2. >>Market Access

Hepatitis C Pricing: Insurers' Cost Benchmarks Would Yield Optimal Price Of $42,000 – Report

 
• By Cathy Kelly

Institute for Clinical and Economic Review reviews how insurers determine when a drug price would require premium increases or coverage restrictions, and suggests $34,000 to $42,000 would be a manageable price range for new hepatitis C treatments based on budget thresholds widely used by payers.

The Institute for Clinical and Economic Review presents an approach to evaluating the price of new drugs for hepatitis C based on budget parameters used by payers in a draft report released Nov. 17.

Based on the approach, it estimates a new combination drug for hepatitis C that cost $34,000 to $42,000 would be...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

EMA Explores Supporting Drug Development For High Unmet Need Disorder Scleroderma

 
• By Neena Brizmohun

While treatments for scleroderma are in development, none are approved for the condition that is associated with high morbidity and mortality. The European Medicines Agency says guidance on how to design development programs for the disorder is needed.

EMA Nod For First MASH Drug Rezdiffra, Cell Therapy Zemcelpro And 11 Others

 
• By Eliza Slawther

Madrigal Pharmaceuticals’ Rezdiffra is on track to become the first medicine approved in the EU for non-cirrhotic metabolic dysfunction-associated steatohepatitis after the European Medicines Agency recommended that it be granted conditional marketing authorization.